Optimum Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Optimum Investment Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12	Closed	-$2K	–	798
2022 Q3	$2K	Hold	12	–	–	﹤0.01%	729
2022 Q2	$2K	Hold	12	–	–	﹤0.01%	758
2022 Q1	$2K	Hold	12	–	–	﹤0.01%	789
2021 Q4	$2K	Hold	12	–	–	﹤0.01%	783
2021 Q3	$2K	Hold	12	–	–	﹤0.01%	794
2021 Q2	$2K	Buy	+12	New	+$2.08K	﹤0.01%	864
2019 Q1	–	Sell	-100	Closed	-$12K	–	1017
2018 Q4	$12K	Hold	100	–	–	﹤0.01%	726
2018 Q3	$17K	Hold	100	–	–	﹤0.01%	763
2018 Q2	$17K	Hold	100	–	–	﹤0.01%	762
2018 Q1	$15K	Buy	+100	New	+$14.7K	﹤0.01%	758
2015 Q1	$60K	Hold	350	–	–	0.02%	475
2014 Q4	$57K	Buy	+350	New	+$58.1K	0.02%	473

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Optimum Investment Advisors's JAZZ Position: Q4 2022 in Review

Optimum Investment Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2022, closing a stake of 12 shares — an estimated $2K sold.

Optimum Investment Advisors first reported a position in JAZZ in Q4 2014 and held it in 12 quarters. The position peaked at $60K in Q1 2015. 485 funds tracked by Wall St. Rank hold JAZZ as of Q4 2022.

Optimum Investment Advisors reported no remaining Jazz Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Optimum Investment Advisors sold 12 Jazz Pharmaceuticals shares in Q4 2022, an estimated $2K.
Optimum Investment Advisors first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 12 quarters.
Optimum Investment Advisors's Jazz Pharmaceuticals position peaked at $60K in Q1 2015.
485 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2022.

Based on Optimum Investment Advisors's 13F filing for Q4 2022, filed 5 Jan 2023.